CliffBio
small molecule

OLEPTRO

TRAZODONE HYDROCHLORIDE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyAngelini →View the full company profile on CliffBio

Drug detail

Brand nameOLEPTRO
Active ingredientTRAZODONE HYDROCHLORIDE
Strength300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2010
Marketing statusDISCN

Listed patents

PatentExpiresType
8133893March 2029substance, product
7829120March 2027product

More from Angelini

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

OLEPTRO patent cliff — loss of exclusivity March 2029 | CliffBio